Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
FGF-dependent regulation of VEGF receptor 2 expression in mice
Masahiro Murakami, … , Brian L. Black, Michael Simons
Masahiro Murakami, … , Brian L. Black, Michael Simons
Published June 1, 2011
Citation Information: J Clin Invest. 2011;121(7):2668-2678. https://doi.org/10.1172/JCI44762.
View: Text | PDF
Research Article Vascular biology Article has an altmetric score of 6

FGF-dependent regulation of VEGF receptor 2 expression in mice

  • Text
  • PDF
Abstract

Numerous studies have suggested a link between the angiogenic FGF and VEGF signaling pathways; however, the nature of this link has not been established. To evaluate this relationship, we investigated VEGF signaling in ECs with disrupted FGF signaling in vitro and in vivo. ECs lacking FGF signaling became unresponsive to VEGF, caused by downregulation of VEGF receptor 2 (VEGFR2) expression after reduced Vegfr2 enhancer activation. FGF mediated VEGFR2 expression via activation of Erk1/2. Transcriptional analysis revealed that Ets transcription factors controlled VEGFR2 expression in an FGF- and Erk1/2-dependent manner. Mice with defective FGF signaling exhibited loss of vascular integrity and reduced vascular morphogenesis. Thus, basal FGF stimulation of the endothelium is required for maintenance of VEGFR2 expression and the ability to respond to VEGF stimulation and accounts for the hierarchic control of vascular formation by FGFs and VEGF.

Authors

Masahiro Murakami, Loc T. Nguyen, Kunihiko Hatanaka, William Schachterle, Pei-Yu Chen, Zhen W. Zhuang, Brian L. Black, Michael Simons

×

Figure 1

FGF regulation of VEGF signaling and VEGFR2 expression.

Options: View larger image (or click on image) Download as PowerPoint
FGF regulation of VEGF signaling and VEGFR2 expression.
(A) Western blot...
(A) Western blot of total cell lysates of BAECs transduced with Ad-GFP or Ad-FGFR1DN and stimulated with FGF1 (50 ng/ml) or VEGF-A (80 ng/ml) for 5 minutes. Cont, control; p-, phosphorylated; t-, total. (B) Quantitative analysis of cellular cGMP levels (n = 3). (C) Quantitative RT-PCR analysis of total RNA isolated from BAECs. Vegfr2 mRNA levels were measured with real-time PCR and normalized to Gapdh expression. Values denote abundance relative to that of untreated BAECs (assigned as 1). (D) Western blotting of total cell lysates isolated from BAECs treated with U0126 at different concentrations for 6 hours in normal growth medium. (E) Quantitative analysis of VEGFR2 levels. (F) BAECs were first transduced with Ad-Null or Ad-FGFR1DN, then the next day with Ad-ME or Ad–ME-LA. Quantitative PCR analysis of VEGFR2 expression was performed (n = 3). (G) Western blotting of total cell lysates showed increased VEGFR2 levels in Ad-FGFR1DN–transduced cells after Ad–ME-LA treatment. ME-LA and FGFR1DN (gray and black arrows, respectively) were detected with an HA antibody. *P < 0.05, **P < 0.01 versus respective control.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
139 readers on Mendeley
See more details